top of page
Understanding Melanocytes: How a Pigment Cell Can Lead to Melanoma
by: OcularCancer.com
July 19, 2025
3 Minute Read

Melanoma is one of the most aggressive forms of cancer. While it represents only about 1 percent of all skin cancer diagnoses, it accounts for the vast majority of skin cancer-related deaths.
When melanocytes become malignant, their potential to spread quickly and resist treatment makes them particularly dangerous. In the case of ocular melanoma, symptoms may be minimal or absent until the disease is quite advanced.
This makes routine eye exams and early detection especially important, particularly for individuals with risk factors such as light eye color, choroidal nevi, or a family history of melanoma.
Understanding Melanocytes: How a Pigment Cell Can Lead to Melanoma
Published: July 19, 2025 | By: OcularCancer.com
We often associate skin color, freckles, or eye shade with genetics and family traits - but at the root of it all lies a specialized cell called the melanocyte. These pigment-producing cells play a crucial role in how our bodies respond to sunlight and environmental damage. Yet under the wrong circumstances, melanocytes can become dangerous, giving rise to an aggressive form of cancer known as melanoma.
Understanding melanocytes - their function, where they reside, and how they transform into cancer - is key to advancing both awareness and early detection efforts, especially for lesser-known forms of the disease such as ocular melanoma.
Melanocytes are neural crest-derived cells that produce melanin, the natural pigment responsible for coloring our skin, hair, and eyes. These cells are part of the body’s first line of defense against ultraviolet (UV) radiation. Melanin acts like a biological shield: it absorbs UV rays and disperses them, helping to prevent DNA damage in skin and eye cells. Although melanocytes account for only about 5 to 10 percent of the cells in the basal layer of the skin’s epidermis, their function is vital for cellular health and pigmentation.
Melanocytes are distributed in several key areas throughout the body. The skin is their most abundant location, particularly in the basal layer of the epidermis. In the eyes, melanocytes are especially concentrated in the uveal tract, which includes the choroid, ciliary body, and iris - regions involved in vision and blood supply within the eye. They are also present in hair follicles, where melanin determines hair color, and in the inner ear, where they help regulate hearing and balance.
Additional populations of melanocytes exist in the leptomeninges, the pigmented membranes surrounding the brain and spinal cord, as well as in mucous membranes such as the nasal passages, oral cavity, and genital tract. This widespread distribution explains why melanoma can occur in many areas, not just on sun-exposed skin.
The primary function of melanocytes is to synthesize melanin, which is packaged into small vesicles called melanosomes. These are then transferred to nearby keratinocytes in the skin or epithelial cells in the eye, where the pigment absorbs harmful UV radiation and reduces oxidative stress.
Beyond their pigmentation role, melanocytes are involved in immune responses, oxidative defense, and cell signaling in both the skin and the eye. In ocular tissues, melanin also plays an optical role by limiting light scatter, which contributes to visual sharpness.
The transformation of melanocytes into melanoma cells is a multi-step process involving both genetic and environmental triggers. Prolonged exposure to ultraviolet radiation is a leading cause of DNA damage in skin melanocytes. However, in non-cutaneous melanomas, such as uveal (ocular) melanoma, UV light is not the main driver. Instead, spontaneous mutations or other risk factors, like fair skin and light colored eyes, may play a larger role.
Cancerous transformation typically involves mutations in critical genes. Some of these, known as oncogenes, drive cells to divide uncontrollably. In skin melanoma, mutations in genes such as BRAF and NRAS are common. In uveal melanoma, mutations in GNAQ and GNA11 are frequently seen, affecting signaling pathways that lead to unchecked melanocyte proliferation.
At the same time, tumor suppressor genes, which normally prevent cell overgrowth or trigger cell death when abnormalities arise, can become inactivated. Key tumor suppressor genes implicated in melanoma include TP53 and BAP1, among others.
Once a melanocyte acquires enough mutations, it begins to divide without regulation, forming a tumor. Unlike benign pigmented lesions such as moles, malignant melanomas invade surrounding tissues and evade immune detection. Over time, advanced melanomas gain the ability to migrate. In ocular melanoma, for example, cancer cells can enter the bloodstream through the highly vascular uveal tract and metastasize to distant organs, most commonly the liver.
Melanoma is one of the most aggressive forms of cancer. While it represents only about 1 percent of all skin cancer diagnoses, it accounts for the vast majority of skin cancer-related deaths. When melanocytes become malignant, their potential to spread quickly and resist treatment makes them particularly dangerous.
In the case of ocular melanoma, symptoms may be minimal or absent until the disease is quite advanced. This makes routine eye exams and early detection especially important, particularly for individuals with risk factors such as light eye color, a choroidal nevus (freckle), or a family history of melanoma.
Melanocytes are small but powerful players in human biology. They protect us from UV radiation, contribute to our identity through pigmentation, and support vital functions such as vision and hearing. Yet when their internal machinery breaks down, these same cells can become the source of one of the deadliest cancers known. By deepening our understanding of melanocytes - where they reside, what they do, and how they become cancerous - we move closer to improving early detection, developing targeted treatments, and ultimately saving lives from melanoma in all its forms.
bottom of page